The division of Biochemistry and Molecular Biology focuses on the therapeutic areas of antibacterials, antivirals, and immunomodulators facing multidrug-resistant pathogens. We mainly identify and evaluate bioactive peptides from natural sources or the in-silico design of chimeric structures with similar functions. We have experience and dedicated staff in the following areas of science: Bioinformatics, molecular modeling, and dynamics; in vitro/in vivo preclinical evaluation; and a newly created advanced technology group for biomolecules.